3 Drugs Stocks Pushing The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices traded up today The three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 60 points (0.4%) at 16,979 as of Wednesday, Aug. 20, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,544 issues advancing vs. 1,461 declining with 193 unchanged.

The Drugs industry as a whole closed the day down 0.7% versus the S&P 500, which was up 0.2%. Top gainers within the Drugs industry included VBI Vaccines ( VBIV), up 3.3%, Aradigm ( ARDM), up 2.9%, Evoke Pharma ( EVOK), up 2.0%, Ruthigen ( RTGN), up 3.1% and Celator Pharmaceuticals ( CPXX), up 2.2%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Ruthigen ( RTGN) is one of the companies that pushed the Drugs industry higher today. Ruthigen was up $0.17 (3.1%) to $5.60 on heavy volume. Throughout the day, 32,142 shares of Ruthigen exchanged hands as compared to its average daily volume of 15,800 shares. The stock ranged in a price between $5.36-$5.77 after having opened the day at $5.36 as compared to the previous trading day's close of $5.43.

Ruthigen has a market cap of $25.8 million and is part of the health care sector. Shares are unchanged year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

3 Drugs Stocks Pushing The Industry Higher

3 Stocks Pushing The Drugs Industry Higher

3 Stocks Pushing The Drugs Industry Lower